TTLTicker Tales
NSE: CHOLAFINFinancial Services

Cholamandalam Investment and Finance Company

Cholamandalam Investment and Finance (Chola), part of the Murugappa Group, is a non-bank lender financing commercial and passenger vehicles, SMEs, home loans and, increasingly, consumer loans.

₹1,586.00▼−7.2%1 yearClosing price, 30 Oct 2026
  • P/E ~24x (near own median)
  • AUM up 25% YoY
  • GNPA improving to 4.44%
  • Down 18% from Aug peak
  • Zero promoter pledge

Updated on 31 Oct 2026 · Data as of 30 Oct 2026

Get this report as a PDF free, straight to your inbox.

Snapshot

Share price
₹1,586.00
30 Oct 2026
52-week range
₹1,354.17 – ₹1,940.00
All-time peak
₹1,940.00
6 Aug 2026 · −18.2% from peak
Dividend yield
0.13%
Price history since
2002
About 24 years of prices
52-week low ₹1,354.17high ₹1,940.00

What's happening

Chola reported Q2 FY27 (Jul-Sep 2026) results around 28 October 2026 - net profit rose 41% YoY to ₹1,630 crore, AUM grew 25% to about ₹2.68 lakh crore, and disbursements jumped 47% to ₹35,872 crore. The same board meeting approved raising up to ₹5,000 crore via a QIP to fund further growth; final pricing and dilution terms are not yet out.

In plain terms

Chola borrows money and lends it out for vehicles, business working capital and consumer needs, earning the spread in between. The lending book is growing fast and profit is up sharply, but the stock has fallen 18% from its August 2026 high as investors worry about rising funding costs squeezing margins and about credit quality in newer, less-tested loan categories like consumer finance. The planned ₹5,000 crore share sale will raise growth capital but will also dilute existing shareholders by an amount not yet disclosed - that tension between 'growing fast' and 'paying more to grow' is the thing to watch.

Quarters

PAT growth has been strong and consistent: Q2 FY27 PAT of ₹1,630 crore is up 41% YoY, with net credit cost falling to 1.4% (from 1.5% QoQ and 1.7% a year ago) as vehicle finance and consumer loan losses eased. AUM growth of 25% YoY in H1 already exceeds management's full-year guidance of 23%, and credit cost is already at the 1.5% full-year target. Management has flagged that funding costs could rise another 10-15 bps in FY27 if rates move up, which would eat into margins even as the loan book keeps growing.

Performance

Heads-up on splits: Cholamandalam Investment and Finance Company has split its shares or issued bonus shares before (most recently 5-for-1 on 14 Jun 2019). A sudden price drop around a split date is usually just the price adjusting for the extra shares, not a crash.

Share price

−7.2% over 1 year

Returns by period

PeriodCholamandalam Investment and Finance CompanyNifty 50Bajaj Finance
3 months−14.3%−5.5%−17.7%
1 year−7.2%−10.9%−10.2%
3 years+40.0%+20.8%+27.5%
5 years+172.0%+28.6%+29.9%

₹100 invested on 1 Nov 2021 became…

  • Cholamandalam Investment and Finance Company₹272
  • Nifty 50₹129
  • Bajaj Finance₹130

Over 5 years the stock is up 171.96% against the Nifty's 28.58% and peer Bajaj Finance's 29.89% - a large outperformance. A 5-for-1 stock split in June 2019 is a cosmetic share-count change, not a spin-off, so it does not distort these comparisons (return series are split-adjusted). Near term the picture has turned: the stock is down 14.27% over 3 months versus the Nifty's -5.46%, and sits 18.2% below its 6 August 2026 peak of ₹1,940, closing at ₹1,586 on 30 October 2026. This is a sector-wide NBFC de-rating and credit-cost repricing, not a corporate-action artifact.

Dividend

Paid in the last 12 months

₹2.00 per share

Dividend yield

0.13%

Dividend yield is the last 12 months of dividends divided by today's share price. A 0.1% yield means every ₹100 of Cholamandalam Investment and Finance Company shares paid about ₹0.1 in dividends over the past year. Past payouts can change.

Recent dividends

DatePer share
21 Jul 2026₹0.70
5 Feb 2026₹1.30
24 Jul 2025₹0.70
7 Feb 2025₹1.30
19 Jul 2024₹0.70
7 Feb 2024₹1.30
25 Jul 2023₹0.70
10 Feb 2023₹1.30

Valuation

At roughly 24x trailing earnings and about 4.5x book, Chola trades close to its own 10-year median multiples (P/E median ~25.5x, P/B median ~4.65x) - not verified beyond this GuruFocus snapshot, check Screener for a second read. That means the stock isn't obviously cheap or expensive relative to its own history; it is cheaper than it was at the August peak simply because the price has fallen while earnings have grown. Why it looks reasonable: earnings and AUM are compounding at 25%+. Whether that's cheap enough depends on whether funding-cost pressure and the upcoming QIP dilution eat into per-share growth from here - that's a judgment call this report won't make for you.

Growth

This is volume-led growth: AUM is up 25% YoY and disbursements 47% YoY, spread across vehicle finance, SME and a fast-scaling consumer loan book (up 133% YoY, though starting from a small base). Margins are under pressure, not expanding - management itself expects funding costs to rise further in FY27 - so the profit growth is coming from doing more business, not from pricing power or a lower cost structure.

Health

Profits are backed by real cash generation typical of a lending business where margin spread funds operations; the better signal here is asset quality, which is improving: gross NPA fell to 4.44% from 4.57% YoY, net NPA to 2.92% from 3.07%, and net credit cost to 1.4% from 1.7%. Capital adequacy of 20.62% (as of 30 Sep 2026) is comfortably above the 15% regulatory floor, with CET1 at 14.88% against a 9% minimum - solvency risk looks low. The real risk here is business risk, not financial risk: a large, fast-growing, not-yet-fully-seasoned book in consumer loans and SME, and vehicle-finance exposure to freight-rate cycles, are what could push credit costs back up. Note: ROCE of 9.7% looks low but is a poor metric for an inherently leveraged lender - ROE (~20.5%) is the more relevant yardstick for this business.

Ownership

Promoters (Murugappa Group, via Cholamandalam Financial Holdings) held about 49.25% as of the March 2026 shareholding pattern, down slightly from 49.72% in December 2025, with FIIs around 24.45% and DIIs around 20.62%. Promoter pledging has been nil from at least June 2023 through March 2026 - a clean signal. We did not find a marquee named retail/HNI investor on the register in available sources; if one exists it isn't reflected in what we could verify here - check Screener's shareholding tab for the full non-institutional list.

The View

The one thing to watch

The finalized QIP pricing/dilution and whether net credit cost holds near 1.4-1.5% as the consumer-loan and SME books season - watch the Q3 FY27 results for the NIM and GNPA trend.

Strengths

  • +AUM grew 25% YoY to ~₹2.68 lakh crore with disbursements up 47% YoY to ₹35,872 crore (Q2 FY27)
  • +Net profit up 41% YoY to ₹1,630 crore with net credit cost falling to 1.4% from 1.7% a year ago
  • +Asset quality improving: gross NPA down to 4.44% (from 4.57%) and net NPA down to 2.92% (from 3.07%)
  • +Capital adequacy at 20.62%, well above the 15% regulatory minimum, with zero promoter pledging

Watchpoints

  • !Stock down 18.2% from its 6 Aug 2026 peak amid a broader NBFC sector de-rating and reported FII selling in mid-cap financials
  • !Board-approved QIP of up to ₹5,000 crore (28 Oct 2026) will dilute shareholders - final size and price are not yet disclosed
  • !Management expects funding costs to rise a further 10-15 bps in FY27, pressuring net interest margins
  • !Consumer loan book (+133% YoY) and SME exposure are fast-growing but less seasoned, and vehicle finance remains sensitive to freight-rate cycles

How sure are we about the data? · Moderate

PAT, AUM, disbursement, GNPA/NNPA and capital adequacy figures for Q2 FY27 were cross-checked across multiple news outlets (Zeebiz, Elets BFSI, GuruFocus earnings-call summary) and are consistent. P/E, P/B, ROE and ROCE are from a single GuruFocus snapshot (~14 Oct 2026) and were not independently cross-checked against Screener - treat as indicative. Shareholding percentages are from a Trendlyne pattern as of the March 2026 quarter; QIP final pricing/share count is not yet public. Care Ratings' August 2026 note on capital adequacy was used for the 20.62% figure.

Keep it for later

Get the Cholamandalam Investment and Finance Company report as a PDF

The full report, neatly laid out with charts and tables, sent to your inbox. Handy to read offline or share.

Free. We use your email only to send this report and the newsletter.

Share this X LinkedIn WhatsApp

← All Nifty 100 companies

Reports are refreshed every quarter, about three days after each company announces its results.

Ticker Tales is not a SEBI-registered investment adviser or research analyst. This report is for learning only and is not investment advice. Data as of 30 Oct 2026.